HighGravityData

Axon Enterprise — Nov 7, 2024 release

Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001069183-24-000055
Open on SEC.gov ↗
Showing in the filing
Adjusted EBITDA margin
“approximately 23.5%”
Period
Q4 FY2024
Measure
Company-defined measure
Source
Prose
All guidance in this release · 16
Adjusted EBITDA margin for FY2024
“approximately 24.6%”
Revenue for Q4 FY2024
“$560 million to $570 million”
Adjusted EBITDA for Q4 FY2024
“$130 million to $135 million”
Revenue expectation for FY2024
“approximately $2.07 billion”
Software-only gross margin target for the long term
“80%”
Portion of total company future contracted r…
“between 15% to 25%”
Adjusted EBITDA margin for Q4 FY2024
“approximately 23.5%”
Adjusted EBITDA margin for Q4 FY2024
“approximately 23.5%”
Adjusted EBITDA for FY2024
“approximately $510 million”
Adjusted EBITDA dollars for FY2024
“approximately $510 million”
Stock-based compensation expenses for FY2024
“approximately $360 million to $380 million”
Stock-based compensation expense for broad-b… for FY2024
“approximately $210 million”
Expected stock-based compensation expense re… for FY2024
“Approximately $170 million”
Stock-based compensation expense related to … for FY2024
“Approximately $43 million”
CapEx for FY2024
“$80 million to $95 million”
Moonshot goal to cut gun-related deaths betw… for FY2033
“50%”
Exhibit 99.1 · the passage around this item
… earlier in the release
Q4 2024 • For the fourth quarter, we expect revenue within the range of $560 million to $570 million, representing greater than 30% annual growth at the midpoint. • We expect Adjusted EBITDA within the range of $130 million to $135 million, representing Adjusted EBITDA margin of approximately 23.5%. ◦ We provide Adjusted EBITDA guidance, rather than net income guidance, due to the inherent difficulty of forecasting certain types of expenses and gains such as stock-based compensation, income tax expenses and gains or losses on marketable securities and strategic investments, which affect net income but not Adjusted EBITDA. We are unable to reasonably estimate the impact of such expenses, which could be material, on net income. Accordingly, we do not provide a reconciliation of projected net income to projected Adjusted EBITDA. Full Year • Axon’s full year 2024 revenue expectation has improved to approximately $2.07 billion, representing greater than 32% annual growth. This is an increase from our prior revenue guidance range of $2.00 billion to $2.05 billion, or 29.5% annual growth at the midpoint. • Axon expects full year 2024 Adjusted EBITDA dollars of approximately $510 million, representing Adjusted EBITDA margin of approximately 24.6%. This is an increase from our prior Adjusted EBITDA guidance range of $460 million to $475 million, which implied Adjusted EBITDA margin of approximately 23.1% • We expect stock-based compensation expenses to be approximately $360 million t
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.